Enovis (ENOV) Operating Margin (2010 - 2026)
Enovis' (ENOV) quarterly Operating Margin came in at 1.11% in Q2 2026, up 948.0% year-on-year from 0.11% in Q2 2025, and up 101.27% on a QoQ basis from 87.22% in Q4 2025.
Enovis (ENOV) Operating Margin (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Operating Margin data on file, last reported at 1.11% in Q2 2026.
- On a quarterly basis, Operating Margin rose 948.0% year-over-year to 1.11% in Q2 2026; TTM through Apr 2026 was 47.0%, a 1038.0% decrease from a year earlier, with the FY2025 full-year figure at 50.01%, down 1320.0% from the prior year.
- Operating Margin for Q2 2026 stood at 1.11%, up from 87.22% in the prior quarter.
- Over the last five years, Operating Margin for ENOV reached as high as 1.41% in Q3 2022 and fell as low as 118.5% in Q4 2024.
- Historically, Operating Margin has averaged 21.95% across 5 years, with a median of 6.28% in 2024.
- Across the five-year window, Operating Margin sank 11723 bps in 2024 and soared 3128 bps in 2025, its largest moves.
- Year by year, Operating Margin stood at 6.9% in 2022, then jumped by 82 bps to 1.26% in 2023, then tumbled by 9269 bps to 118.5% in 2024, then climbed by 26 bps to 87.22% in 2025, then soared by 101 bps to 1.11% in 2026.
- Per Business Quant data, the three most recent Operating Margin figures were 1.11% in Q2 2026, 87.22% in Q4 2025, and 101.74% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 1.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.11% |
| Dec 31, 2025 | -87.22% |
| Oct 3, 2025 | -101.74% |
| Jul 4, 2025 | -2.98% |
| Apr 4, 2025 | -8.37% |
| Dec 31, 2024 | -118.50% |
| Sep 27, 2024 | -6.28% |
| Jun 28, 2024 | -8.42% |
| Mar 29, 2024 | -6.78% |
| Dec 31, 2023 | -1.26% |
| Sep 29, 2023 | -4.91% |
| Jun 30, 2023 | -3.38% |
| Mar 31, 2023 | -6.15% |
| Dec 31, 2022 | -6.90% |
| Sep 30, 2022 | -4.67% |
| Jul 1, 2022 | 1.41% |
| Apr 1, 2022 | -8.16% |
| Dec 31, 2021 | -4.56% |
| Oct 1, 2021 | -4.48% |
| Jul 2, 2021 | -2.91% |